Determination of the toxic threshold of lolitrem B in cattle eating endophye-infected perennial ryegrass
DOI:
https://doi.org/10.33584/rps.13.2006.3152Abstract
Perennial ryegrass (Lolium perenne) straw is used as a feed for livestock and horses. Some straw is infected with the endophyte, Neotyphodium lolii, which produces lolitrem tremorgens. Ingesting of the toxin produces clinical "ryegrass staggers." A 28 day feeding trail was conducted using 61 Black Angus, pure and crossbred cattle. The cattle were fed one of three levels of lolitrem B in chopped perennial ryegrass straw ranging from 0 ppb up to 3058 ppb. Four Japanese Wagyu crossbred cattle were fed chopped ryegrass straw containing 1400 ppb lolitrem B. The cattle were evaluated and scored twice a day for clinical signs of gait difficulties. Cattle consuming 1400 ppb lolitrem B did not show any overt clinical signs. After 14 days, 7 out of 15 cattle in the 1954 ppb lolitrem B group showed clinical signs of ataxia, stiffness, and tremors as seen in ryegrass staggers. All of the cattle in the positive control group of up to 3058 ppb lolitrem B with a 4 week mean of 2574 ppb developed clinical signs of staggers. None of the Wagyu cattle at 1400 ppb lolitrem B developed clinical signs. A dose response curve was developed based on the results of this study coupled with a prior study for use in the testing laboratory. Keywords: lolitrem B, perennial ryegrass, Lolium perenne, endophyte fungus, Neotyphodium lolii, cattle, threshold levelsDownloads
Published
How to Cite
Issue
Section
License
Copyright
This work is licensed under a Creative Commons Attribution-Non Commercial-NoDerivatives 4.0 International License. Rights granted to the New Zealand Grassland Association through this agreement are non-exclusive. You are free to publish the work(s) elsewhere and no ownership is assumed by the NZGA when storing or curating an electronic version of the work(s). The author(s) will receive no monetary return from the Association for the use of material contained in the manuscript. If I am one of several co-authors, I hereby confirm that I am authorized by my co-authors to grant this Licence as their agent on their behalf. For the avoidance of doubt, this includes the rights to supply the article in electronic and online forms and systems.



